We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

By HospiMedica International staff writers
Posted on 12 Sep 2025

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. More...

Diagnosis is complex because tumors can mimic other soft tissue cancers, and the disease frequently shows resistance to chemotherapy. A new case study has highlighted the importance of early and precise diagnosis using immunohistochemistry, combined with complete surgical removal and targeted postoperative care, in improving survival for affected patients.

Researchers from the All India Institute of Medical Sciences (AIIMS, New Delhi, India) and the Alluri Sitaramaraju Academy of Medical Sciences (Andhra Pradesh, India) have described the case involving a 30-year-old woman with a gradually enlarging swelling in her upper right thigh. Imaging revealed a well-defined lesion, and biopsy suggested a spindle cell neoplasm. Following surgical excision, the mass was diagnosed as Grade 2 adult fibrosarcoma, and the patient received external beam radiation therapy to reduce the risk of recurrence.

The research, published in the journal Oncoscience, showed that advanced imaging tools such as MRI and PET-CT, combined with immunohistochemistry, were critical to confirming the diagnosis and distinguishing fibrosarcoma from other tumors. The cancer’s aggressive nature was underscored by its tendency to recur, reinforcing the need for accurate pathology and multimodal treatment approaches.

In addition to clinical management, the research emphasizes how molecular research has identified genetic alterations like NTRK3 fusions and chromosome 12q amplifications, which may help select patients for targeted therapies. These findings also reveal how fibrosarcoma disrupts immune and hormonal systems, creating a tumor-supportive environment. Future treatment strategies may therefore combine surgery, radiotherapy, and targeted therapies to improve long-term outcomes.

“Chemotherapy and immunotherapy play complementary roles in disease management, with emerging strategies targeting matrix metalloproteinases and tumor microenvironment interactions to enhance chemosensitivity and overcome drug resistance,” stated the authors.

Related Links:
AIIMS 
Alluri Sitaramaraju Academy of Medical Sciences


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Pediatric Mask
Respire SOFT
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The nasal spray is created using the ‘Nano-in-Micron’ technology platform. The micron-sized powder is inhaled and travels along the nose-to-brain pathway, bypassing the blood-brain barrier to deliver the drug directly to the brain (Photo courtesy of The University of Hong Kong

New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke

Ischemic stroke, caused by arterial occlusion in the brain, requires time‑critical intervention to limit neuronal loss. Many patients arrive outside the narrow window for thrombolysis or thrombectomy,... Read more

Surgical Techniques

view channel
Image: MUSA-3 is designed to assist surgeons during open super‑microsurgical procedures by downscaling and stabilizing hand movements (Photo courtesy of Microsure)

Robotic Microsurgery System Gains CE Mark for Clinical Use in Europe

Microsure (Eindhoven, The Netherlands) announced on May 7, 2026 that its MUSA-3 system received CE mark approval, enabling clinical use in Europe. The milestone marks the company’s transition from product... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.